This is a draft version - Page is not published

$134.3 Million
Lexicon
Lexicon Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering and PIPE Offering
Active Bookrunner
$150.0 Million
Cogent
Cogent Biosciences
Confidentially Marketed Follow-On Offering
Active Bookrunner
$172.5 Million
DayOne
Day One Biopharmaceuticals, Inc.
Confidentally Marketed Follow-On Offering
Active Bookrunner
$1.2 Billion
Corebridge
Corebridge Financial, Inc
Follow-On Offering
Active Bookrunner
$318.8 Million
Enfusion
Enfusion
Initial Public Offering
Active Bookrunner
$1.7 Billion
AIG
Corebridge
Corebridge
Initial Public Offering
Active Bookrunner
$49.6 Million
TELA Bio, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$68.3 Million
Reneo
Reneo Pharmaceuticals
Confidentially Marketed Follow-On Offering
Active Bookrunner
$621.0 Million
Acelyrin
Acelyrin, Inc.
Initial Public Offering
Active Bookrunner
$100.0 Million
Protagonist
Protagonist Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2023 Piper Sandler Companies. Since 1895. All rights reserved.